TP53 and malignant colon neoplasm: From our experimental results, the sensitivity of HT29 colon cancer cells to oxaliplatin is greatly increased after the transfection of TRIM29, suggesting that TRIM29 may increase the sensitivity of HT29 to oxaliplatin by blocking the function of mutant P53.